OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer


Recommended Conferences for Medical Affairs

Medical Affairs

As per available reports about10 relevant journals, 71 Conferences, 6 workshops are presently dedicated exclusively to Medical Affairs and about 1543 articles are being published on Medical Affairs.

Medical Affairs is responsible for developing and executing medical marketing strategies and tactics for a brand or therapeutic area.  Medical Affairs is a function in pharmaceuticals, medical device and healthcare organizations. Medical Affairs actually oversees many responsibilities in the areas of medical communication, MSL etc. A medical affair is a critical part of the pharmaceutical industry. There is no real equivalent to medical affairs in biotechnology, yet it plays an ever-increasing and important role in that industry as well. After describing the role of medical affairs and its key functions, we present a case that highlights its importance both in prelaunch and during launch. The case demonstrates a new and innovative way companies can use corporate partnerships too flexibly and efficiently maximize medical affairs support. The traditional bio manufacturing model includes two main pillars: an R&D organization in charge of developing new products and a commercial organization in charge of marketing and selling those products. Pharmaceutical manufacturing has a similar split: a development group (responsible for getting FDA approval for drug products) and a commercial team (that markets and sells those products). One big difference, however, is that the biopharmaceutical industry lacks an additional group to act as a bridge between development and commercialization. This is the role of medical affairs.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance

Medical affairs originally emerged as a reaction to increasing pressures from regulators to separate medical and commercial functions. Companies were experiencing increasing internal demands to focus the role of development on generating and developing new products rather than on managing products after FDA approval. Over the past 25 years, continued regulatory pressure shifted a number of commercial activities to people with medical expertise, most often to medical affairs groups. Thus medical affairs has evolved into a separate medical organization that often sits within development organizations but primarily works on post approval activities and has both the scientific and clinical expertise to support commercial products. Examples of medical affairs functions include
• Managing key thought-leader relationships
• Publishing data from corporate-sponsored trials
• Presenting educational information about a product or therapeutic landscape
• Answering questions from healthcare providers regarding product safety or efficacy that is not addressed in a product’s label
• Supporting research initiatives outside labelled indications for marketed products.
For a company whose product is years away from commercialization, the information above may be interesting, yet may seem irrelevant. It may be thought-provoking, but otherwise meaningless in day-to-day operations of a typical biotechnology company that is involved more with drug discovery than with drug development and commercialization. Although gaining a deep understanding of medical affairs may not seem immediately relevant, understanding the overall purpose of it and the functions it performs becomes crucial as a product moves closer to commercialization. Medical affairs can sometimes be overlooked due to competing priorities such as establishing a commercial organization, ensuring a smooth path toward regulatory approval, and creating and validating a stable and reliable manufacturing supply chain. However, a number of key medical affairs functions are critical at the time of product launch. The foundation for such functions must be laid 12–24 months before launch for this important department to deliver maximum value to a company. Medical communications/publications is a medical affairs group that directs and plans for all drug-related publications such as abstracts, posters, and manuscripts. Such communications are essential for product commercialization. The group is also responsible for developing a strategic plan that integrates and aligns the timing of clinical trial data locks with the release of key data points at scientific meetings. That plan outlines the timing of abstract submissions and defines when key manuscripts can and should be published in the years leading up to and following a launch. This includes publication of interim data (if available) for either early stage or pivotal trials, which can occur months to years before drug approval. To maximize the value and effectiveness of medical affairs, this department should be formed about one to two years in advance of product launch. That period will allow a medical affairs team to become familiar with the product, understand related issues, and become experts in the group’s wide variety of roles and responsibilities. Understanding the capabilities and functions of medical affairs and the timing for when their functions are needed is a critical component of preparing for and executing a successful drug product launch.

Market Analysis

The market was valued at US$1.56 billion in 2013 and is estimated to reach a value of US$4.49 billion by the end of 2020.With the help of regulatory affairs outsourcing, life science, pharmaceutical, and medical device manufacturing companies are able to get their drugs or devices approved or launched in the global market. Regulatory affairs outsourcing by biopharmaceutical companies has minimized losses due to recalls and product approval delays. Regulatory affairs service providers also provide effective services such as clinical trial services, medical writing, and pharmacovigilance to biotech, pharma, and medical device companies.

International symposium and workshops

  • VIth Asia pacific pharma congress on July 14-16, 2016, Kuala lumpur, Malaysia.
  • VIIth   Annual global Pharma Summit June 20-22, 2016 New Orleans, USA
  • Vth  Global Pharmacists Annual Meeting July 11-13, 2016 Brisbane, Australia

          List of Best International Conferences

  • 6th Pharmaceutical Regulatory Affairs  and IPR Conference September 12-14, 2016 San Antonio, USA
  • 7th Analytical and Bioanalytical Techniques Conference, September 29-October 01, 2016 Miami, USA
  • Pharma Conference, August 25-27, 2015 Valencia, Spain
  • 8th Pharmaceutics and Novel Drug Delivery Systems Conference, March 07-09, 2016 Madrid, Spain
  • Drug Formulation and Bioavailability Conference June 06-08, 2016 Beijing, China
  • Pharma Marketing Conference November 17-19, 2016 Alicante, Spain
  • 6th Pharmacovigilance Conference Canada August 01-03, 2016 Toronto, Canada
  • 4th  GMP, GCP and Quality Control Conference October 26-28, 2015 Hyderabad, India
  • Pharma Conference Middle East November 02-04, 2015 Dubai, UAE
  • Industrial Pharmacy Conference April 11-12, 2016 Dubai, UAE
  • 3rd Annual International Conference on Pharmacology and Pharmaceutical Sciences (PHARMA) 26-27 October 2015, Bangkok Thailand
  •  Pharma Africa Market Access Conference 24 - 25 September 2015 London, UK
  • International Conference and Expo on Bio pharmaceutics September 21-22, 2015 Baltimore, MD, USA

    Relevant Companies
    •Abbott Laboratories
    •Ego Pharmaceuticals
    •Eli Lilly and Company
    •General Pharma
    •Getz Pharma
    •Glenmark Pharmaceuticals
    •Avella Specialty Pharmacy
    •Axcan Pharma
    •Aurobindo Pharma
    •Daiichi Sankyo
    •Dainippon Sumitomo Pharma
    •Dawakhana Shifaul Amraz
    •Diabetology Ltd
    •Diffusion Pharmaceuticals
    •Dr. Reddy's Laboratories
    Relevant Associations
    •Regulations & Guidelines - Indian Pharmaceutical Association
    •Drugs Control - Indian Pharmacist Association
    •Central Drugs Standard Control Organization
    •Indian Drug Manufacturers' Association
    •DIA- Drug Information Association
    •The California Naturopathic Doctors Association
    •Texas Pharmacy Today - Texas Pharmacy Association
    •International Harm Reduction Association
    •American Pharmacists Association (APhA)
    •American Society for Pharmacy Law
    •American Society of Consultant Pharmacists Foundation
    •American Society of Consultant Pharmacists (ASCP)
    •American Society of Health-System Pharmacists (ASHP)
    •National Community Pharmacists Association (NCPA)
    •International Pharmaceutical Federation (FIP)
    •European Pharmaceutical Union (EPU)
    •Pharmaceutical Group of the European Union (PGEU)
    •European Association of Employed Community Pharmacists in Europe (EPhEU)
    •Pharmaceutical Society of Australia
    •The Brazilian Association of Regulatory Agencies
    •Insurance Regulatory Committee
    •Compliance & Regulation(IBABC)
    •EAP: Regulations
    •Amusement Ride Safety Regulations and Standards (IAAPA)
    •Commonwealth Pharmacists Association (CPA)

This page will be updated regularly.

This page was last updated on 14th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
+1-702-508-5200 Ext:8051

Program Enquiries
Media Partners | Advertising